Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy

被引:0
作者
R. Guner
I. Hasanoglu
S. Keske
A. K. Kalem
M. A. Tasyaran
机构
[1] Ataturk Education and Research Hospital,
来源
Infection | 2011年 / 39卷
关键词
Tigecycline; Carbapenem-resistant; Carbapenem-resistant ;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:515 / 518
页数:3
相关论文
共 119 条
[1]  
Gordon NC(2010)Multidrug-resistant Int J Antimicrob Agents 35 219-226
[2]  
Wareham DW(2009): mechanisms of virulence and resistance Infez Med 17 236-239
[3]  
Ricciardi R(2007)In vitro activity of tigecycline against multidrug-resistant Emerg Infect Dis 13 97-103
[4]  
Ricciardi AM(2008) clinical isolates Eur J Clin Microbiol Infect Dis 27 607-612
[5]  
Danzi G(2005)Multidrug-resistant J Antimicrob Chemother 56 470-480
[6]  
Sunenshine RH(1988) infection mortality rate and length of hospitalization Am J Infect Control 16 128-140
[7]  
Wright MO(2006)Bloodstream infection due to N Engl J Med 355 2691-2693
[8]  
Maragakis LL(1992) spp.: epidemiology, risk factors and impact of multi-drug resistance Infect Control Hosp Epidemiol 13 606-608
[9]  
Harris AD(2009)Tigecycline J Antimicrob Chemother 63 775-780
[10]  
Song X(2009)CDC definitions for nosocomial infections, 1988 J Infect 58 273-284